Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection

Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis

(2013) Ashwin S. Dharmadhikari et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Can Accurately Differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (Sensu Stricto)

(2013) S.-H. Teng et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

(2013) J P Clancy et al.   THORAX

Mouse Model for Efficacy Testing of Antituberculosis Agents via Intrapulmonary Delivery

(2012) Mercedes Gonzalez-Juarrero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Talking Mycobacterium abscessus Blues

(2011) D. E. Griffith   CLINICAL INFECTIOUS DISEASES

A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

(2009) K. A. Nash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria

(2008) R. Greendyke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections

(2008) P. Meers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Efficacy of Clarithromycin and the Bicyclolide EDP‐420 againstMycobacterium aviumin a Mouse Model of Pulmonary Infection

(2008) Luiz E. Bermudez et al.   JOURNAL OF INFECTIOUS DISEASES

Delivery systems to increase the selectivity of antibiotics in phagocytic cells

(2007) Elsa Briones et al.   JOURNAL OF CONTROLLED RELEASE